Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

324 Views

Poster Session: COVID-19: Treatment

1149 - Resistance Analyses of Patient Viral Samples from the Remdesivir Phase 3 Adaptive COVID-19 Treatment Trial-1 (ACTT-1)

Friday, October 21, 2022

12:15 PM – 1:30 PM US ET

Location: Hall B + C

The ePoster content is available to users who are logged in.<br><br>Please click the login button at the top right corner and then come back here to use this button.

Presenting Author(s)

Charlotte Hedskog, PhD (she/her/hers)

Senior Research Scientist
Gilead Sciences Inc
Foster City, California, United States

Co-Author(s)

LR

Lauren Rodriguez, PhD

Gilead Sciences Inc
Foster City, California, United States
JB

John H. Beigel, MD

The National Institute of Allergy and Infectious Diseases, National Institutes of Health
Rockville, Maryland, United States
WD

Walla Dempsey, PhD

The National Institute of Allergy and Infectious Diseases, National Institutes of Health
Rockville, Maryland, United States
AG

Alexander L. Greninger, MD, PhD

Assistant Professor
University of Washington
Seattle, Washington, United States
PR

Pavitra Roychoudhury, MSc,PhD

University of Washington
Seattle, Washington, United States
MH

Meei-Li Huang, PhD

Research Scientist
University of Washington
Seattle, Washington, United States
KJ

Keith R. Jerome, MD

University of Washington
Seattle, Washington, United States
LH

Linhui Hao, PhD

University of Washington
Seattle, Washington, United States
RI

Renee Ireton, PhD

University of Washington
Seattle, Washington, United States
MG

Michael Gale, Jr., PhD

University of Washington
Seattle, Washington, United States
JL

Jiani Li, PhD

Gilead Sciences Inc
Foster City, California, United States
JP

Jason Perry, PhD

Gilead Sciences Inc
Foster City, California, United States
DH

Dong Han, MS

Gilead Sciences Inc
Foster City, California, United States
GC

Gregory Camus, PhD

Sr Research Scientist II
Gilead Sciences Inc
Foster City, California, United States
DP

Danielle P. Porter, PhD

Sr. Director
Gilead Sciences Inc
Foster City, California, United States